2014
DOI: 10.1097/01.dss.0000452653.52507.d4
|View full text |Cite
|
Sign up to set email alerts
|

Successful Use of the Microsecond 1,064-nm Nd

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 3 publications
0
4
0
Order By: Relevance
“…Two case series with a total of 14 patients by Ezra et al, in 2016 and 2014, described the use of microsecond neodymium-doped yttrium aluminum garnet laser (Nd:YAG; 1064 nm) for management of ectropion and eclabium, secondary to scar contractures post-MMS. 23 , 24 Of 14 patients who underwent microsecond Nd:YAG laser treatment, 1 patient showed improvement of ectropion and 7 experienced complete resolution of ectropion or eclabium, demonstrating a 50% overall success rate. 23 , 24 Regarding the frequency of treatments, 1 to 3 treatments at 1- to 2-month intervals were reported to have good clinical outcomes for patients.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Two case series with a total of 14 patients by Ezra et al, in 2016 and 2014, described the use of microsecond neodymium-doped yttrium aluminum garnet laser (Nd:YAG; 1064 nm) for management of ectropion and eclabium, secondary to scar contractures post-MMS. 23 , 24 Of 14 patients who underwent microsecond Nd:YAG laser treatment, 1 patient showed improvement of ectropion and 7 experienced complete resolution of ectropion or eclabium, demonstrating a 50% overall success rate. 23 , 24 Regarding the frequency of treatments, 1 to 3 treatments at 1- to 2-month intervals were reported to have good clinical outcomes for patients.…”
Section: Resultsmentioning
confidence: 99%
“… 23 , 24 Of 14 patients who underwent microsecond Nd:YAG laser treatment, 1 patient showed improvement of ectropion and 7 experienced complete resolution of ectropion or eclabium, demonstrating a 50% overall success rate. 23 , 24 Regarding the frequency of treatments, 1 to 3 treatments at 1- to 2-month intervals were reported to have good clinical outcomes for patients. While transient erythema was noted 1 to 2 hours post-treatment, no recurrence nor adverse events were noted.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations